FUB-144
 | |
| Systematic (IUPAC) name | |
|---|---|
|
[1-(4-Fluorobenzyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| ChemSpider | 30646792 |
| Chemical data | |
| Formula | C23H24FNO |
| Molar mass | 349.44 g/mol |
| |
| |
FUB-144 (also known as FUB-UR-144) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is an analogue of UR-144 and XLR-11 where the pentyl chain has been replaced with fluorobenzyl.
Legal status
Sweden's public health agency suggested classifying FUB-144 as hazardous substance on March 24, 2015.[2]
See also
References
- ↑ "FUB-144". Southern Association of Forensic Scientists. Retrieved 23 July 2015.
- ↑ "Fler ämnen föreslås bli klassade som narkotika eller hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.
This article is issued from Wikipedia - version of the Friday, February 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.